{"count": 4, "results": [{"_id": "36921584", "pmid": 36921584, "title": "Differential effects of metformin on immune-mediated and androgen-mediated non-cancer skin diseases in diabetes patients: a retrospective cohort study.", "journal": "Dermatology", "authors": ["Tseng CH"], "date": "2023-03-15T00:00:00Z", "doi": "10.1159/000530077", "meta_date_publication": "2023 Mar 15", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.85, "text_hl": "Differential effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on immune-mediated and androgen-mediated @<m>DISEASE_Nonsyndromic_Holoprosencephaly</m> @DISEASE_MESH:C580335 @@@non-@@@@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@skin diseases@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ @SPECIES_9606 @@@patients@@@: a retrospective cohort study.", "citations": {"NLM": "Tseng CH. Differential effects of metformin on immune-mediated and androgen-mediated non-cancer skin diseases in diabetes patients: a retrospective cohort study. Dermatology. 2023 Mar 15;():. PMID: 36921584", "BibTeX": "@article{36921584, title={Differential effects of metformin on immune-mediated and androgen-mediated non-cancer skin diseases in diabetes patients: a retrospective cohort study.}, author={Tseng CH}, journal={Dermatology}}"}}, {"_id": "15991679", "pmid": 15991679, "title": "[Treatment experience with metformin in polycystic ovary syndrome].", "journal": "Orv Hetil", "authors": ["Petrányi G"], "date": "2005-05-22T00:00:00Z", "meta_date_publication": "2005 May 22", "meta_volume": "146", "meta_issue": "21", "meta_pages": "1151-5", "score": 50057.117, "text_hl": "Based on the favourable international experience with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the most common female @DISEASE_Endocrine_System_Diseases @DISEASE_MESH:D004700 @@@endocrine disease@@@, the @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, which has @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ in the background, the author's treatment advice has been this in such cases since early 2002: for sexually active @SPECIES_9606 @@@women@@@ who do not want to become pregnant for the time being, anti-androgenic contraceptive pill; for those who do not want to take contraceptives, contraceptives are contraindicated, or who do want to conceive, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. 44/71 @<m>DISEASE_Nonsyndromic_Holoprosencephaly</m> @DISEASE_MESH:C580335 @@@non@@@-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ opted for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. ", "citations": {"NLM": "Petrányi G. [Treatment experience with metformin in polycystic ovary syndrome]. Orv Hetil. 2005 May 22;146(21):1151-5. PMID: 15991679", "BibTeX": "@article{15991679, title={[Treatment experience with metformin in polycystic ovary syndrome].}, author={Petrányi G}, journal={Orv Hetil}, volume={146}, number={21}, pages={1151-5}}"}}, {"_id": "29988362", "pmid": 29988362, "pmcid": "PMC6023991", "title": "Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis", "journal": "Front Microbiol", "authors": ["Ma W", "Chen J", "Meng Y", "Yang J", "Cui Q", "Zhou Y"], "date": "2018-06-22T00:00:00Z", "doi": "10.3389/fmicb.2018.01336", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "1336", "score": 50052.062, "text_hl": "This result underscores the potential effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on gut microbiome homeostasis, which may contribute to the treatment of @<m>DISEASE_Nonsyndromic_Holoprosencephaly</m> @DISEASE_MESH:C580335 @@@non-@@@@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic diseases@@@.", "citations": {"NLM": "Ma W, Chen J, Meng Y, Yang J, Cui Q, Zhou Y. Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis Front Microbiol. 2018;9():1336. PMID: 29988362", "BibTeX": "@article{29988362, title={Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis}, author={Ma W and Chen J and Meng Y and Yang J and Cui Q and Zhou Y}, journal={Front Microbiol}, volume={9}, pages={1336}}"}}, {"_id": "24682913", "pmid": 24682913, "title": "Pantoprazole may improve beta cell function and diabetes mellitus.", "journal": "J Endocrinol Invest", "authors": ["Inci F", "Atmaca M", "Ozturk M", "Yildiz S", "Koceroglu R", "Sekeroglu R", "Ipekci SH", "Kebapcilar L"], "date": "2014-05-01T00:00:00Z", "doi": "10.1007/s40618-013-0040-y", "meta_date_publication": "2014 May", "meta_volume": "37", "meta_issue": "5", "meta_pages": "449-54", "score": 50029.383, "text_hl": "METHODS: Seventy-nine male @SPECIES_9606 @@@patients@@@ (38 @<m>DISEASE_Nonsyndromic_Holoprosencephaly</m> @DISEASE_MESH:C580335 @@@non-@@@@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ and 41 @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type-2 diabetic@@@ receiving only @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy) were followed for 12 weeks after @CHEMICAL_Pantoprazole @CHEMICAL_MESH:D000077402 @@@pantoprazole@@@ 40 mg/day was given. ", "citations": {"NLM": "Inci F, Atmaca M, Ozturk M, Yildiz S, Koceroglu R, Sekeroglu R, Ipekci SH, Kebapcilar L. Pantoprazole may improve beta cell function and diabetes mellitus. J Endocrinol Invest. 2014 May;37(5):449-54. PMID: 24682913", "BibTeX": "@article{24682913, title={Pantoprazole may improve beta cell function and diabetes mellitus.}, author={Inci F and Atmaca M and Ozturk M and Yildiz S and Koceroglu R and Sekeroglu R and Ipekci SH and Kebapcilar L}, journal={J Endocrinol Invest}, volume={37}, number={5}, pages={449-54}}"}}]}